ScoreWhy is Predictive Oncology, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.76
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -33.94%, its profits have risen by 13.4%
3
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 15.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -33.94% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Predictive Oncology, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Predictive Oncology, Inc.
-33.94%
0.74
1129.07%
S&P 500
15.76%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-11.04%
EBIT Growth (5y)
3.47%
EBIT to Interest (avg)
-12.76
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.57
Sales to Capital Employed (avg)
0.19
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.18%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.07
EV to EBIT
-0.57
EV to EBITDA
-0.60
EV to Capital Employed
-0.08
EV to Sales
5.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
NET SALES(HY)
At USD 3.25 MM has Grown at 2,776.58%
OPERATING CASH FLOW(Y)
Highest at USD 11.5 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 175.47 times
RAW MATERIAL COST(Y)
Fallen by -99.99% (YoY
PRE-TAX PROFIT(Q)
At USD -4.08 MM has Grown at 43.24%
NET PROFIT(Q)
At USD -4.08 MM has Grown at 43.24%
-10What is not working for the Company
NET PROFIT(HY)
At USD -7.49 MM has Grown at -75.72%
ROCE(HY)
Lowest at -1,565.24%
Here's what is working for Predictive Oncology, Inc.
Net Sales
At USD 3.25 MM has Grown at 2,776.58%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Operating Cash Flow
Highest at USD 11.5 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Highest at 175.47 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Pre-Tax Profit
At USD -4.08 MM has Grown at 43.24%
over average net sales of the previous four periods of USD -7.19 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD -4.08 MM has Grown at 43.24%
over average net sales of the previous four periods of USD -7.19 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by -99.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
